MedPath

Role of dexmedetomidineas an analgesic in muscle pain in electro convulsive therapy

Not Applicable
Completed
Conditions
Health Condition 1: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
Registration Number
CTRI/2021/10/037656
Lead Sponsor
IMS AND SUM HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

ASA-1, 2, age 18 - 65 years, Electroconvulsive therapy.

Exclusion Criteria

ASA- Class 3 or higher, uncontrolled hypertension, patients with a poor cardiopulmonary reserve and with body mass index (BMI) >30 kg/m2, renal failure, decompensated cirrhosis, being pregnant, or refusal to provide written informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath